Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome
- PMID: 20802024
- DOI: 10.1182/blood-2010-04-280313
Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome
Abstract
To identify cytogenetic risk factors predicting outcome in children with advanced myelodysplastic syndrome, overall survival of 192 children prospectively enrolled in European Working Group of Myelodysplastic Syndrome in Childhood studies was evaluated with regard to karyotypic complexity. Structurally complex constitutes a new definition of complex karyotype characterized by more than or equal to 3 chromosomal aberrations, including at least one structural aberration. Five-year overall survival in patients with more than or equal to 3 clonal aberrations, which were not structurally complex, did not differ from that observed in patients with normal karyotype. Cox regression analysis revealed the presence of a monosomal and structurally complex karyotype to be strongly associated with poor prognosis (hazard ratio = 4.6, P < .01). Notably, a structurally complex karyotype without a monosomy was associated with a very short 2-year overall survival probability of only 14% (hazard ratio = 14.5; P < .01). The presence of a structurally complex karyotype was the strongest independent prognostic marker predicting poor outcome in children with advanced myelodysplastic syndrome.
Trial registration: ClinicalTrials.gov NCT00047268 NCT00662090.
Similar articles
-
Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.Haematologica. 2015 Mar;100(3):400-8. doi: 10.3324/haematol.2014.116715. Epub 2014 Dec 31. Haematologica. 2015. PMID: 25552702 Free PMC article.
-
Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome.J Clin Oncol. 2013 Mar 1;31(7):916-22. doi: 10.1200/JCO.2012.41.6073. Epub 2013 Jan 14. J Clin Oncol. 2013. PMID: 23319689
-
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.Cancer. 2017 Jul 15;123(14):2661-2670. doi: 10.1002/cncr.30632. Epub 2017 Mar 21. Cancer. 2017. PMID: 28324640
-
Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes.Leuk Lymphoma. 1996 Oct;23(3-4):253-66. doi: 10.3109/10428199609054828. Leuk Lymphoma. 1996. PMID: 9031106 Review.
-
Relapse and cytogenetic evolution in myeloid neoplasms.Panminerva Med. 2017 Dec;59(4):308-319. doi: 10.23736/S0031-0808.17.03380-8. Panminerva Med. 2017. PMID: 29144072 Review.
Cited by
-
Response to treatment with azacitidine in children with advanced myelodysplastic syndrome prior to hematopoietic stem cell transplantation.Haematologica. 2016 Dec;101(12):1508-1515. doi: 10.3324/haematol.2016.145821. Epub 2016 Aug 18. Haematologica. 2016. PMID: 27540140 Free PMC article.
-
The role of genetic factors in pediatric myelodysplastic syndromes with different outcomes.BMC Pediatr. 2024 Jan 8;24(1):28. doi: 10.1186/s12887-023-04492-2. BMC Pediatr. 2024. PMID: 38191334 Free PMC article.
-
Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan.Int J Hematol. 2014 Nov;100(5):478-84. doi: 10.1007/s12185-014-1674-z. Epub 2014 Sep 27. Int J Hematol. 2014. PMID: 25261124
-
-7/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity.Oncogene. 2015 May 7;34(19):2413-25. doi: 10.1038/onc.2014.196. Epub 2014 Jul 7. Oncogene. 2015. PMID: 24998854 Review.
-
Association of unbalanced translocation der(1;7) with germline GATA2 mutations.Blood. 2021 Dec 9;138(23):2441-2445. doi: 10.1182/blood.2021012781. Blood. 2021. PMID: 34469508 Free PMC article. No abstract available.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical